APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radioisotopes in Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Radioisotopes in Medicine Industry Growth and Trends Forecast to 2032

1 February 2026100 pages

Choose your research edition.

Industry ResearchRadioisotopes in Medicine Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Radioisotopes in Medicine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Radioisotopes in Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radioisotopes in Medicine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Radioisotopes in Medicine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Radioisotopes in Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Radioisotopes in Medicine include ANSTO, China National Nuclear Corporation, Eckert & Ziegler Strahlen, IRE, Nordion, NorthStar Medical Radioisotopes, NRG, NTP Radioisotopes and Polatom, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Radioisotopes in Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Radioisotopes in Medicine market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Radioisotopes in Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Radioisotopes in Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Radioisotopes in Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Radioisotopes in Medicine Market by Company

ANSTO

China National Nuclear Corporation

Eckert & Ziegler Strahlen

IRE

Nordion

NorthStar Medical Radioisotopes

NRG

NTP Radioisotopes

Polatom

Rosatom

SHINE Technologies

Radioisotopes in Medicine Segment by Type

Tc-99m

Iodine Radioisotopes

Cobalt-60

Others

Radioisotopes in Medicine Segment by Application

Nuclear Therapy

Equipment Radioactive Source

Diagnosis

Radioisotopes in Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioisotopes in Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radioisotopes in Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioisotopes in Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radioisotopes in Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Radioisotopes in Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tc-99m Table 2. Major Company of Iodine Radioisotopes Table 3. Major Company of Cobalt-60 Table 4. Major Company of Others Table 5. Global Radioisotopes in Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 7. Global Radioisotopes in Medicine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Radioisotopes in Medicine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Radioisotopes in Medicine Sales Market Share in Value by Type (2021-2026) Table 10. Global Radioisotopes in Medicine Price by Type (2021-2026) & (USD/t) Table 11. Global Radioisotopes in Medicine Sales by Type (2027-2032) & (t) Table 12. Global Radioisotopes in Medicine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Radioisotopes in Medicine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Radioisotopes in Medicine Sales Market Share in Value by Type (2027-2032) Table 15. Global Radioisotopes in Medicine Price by Type (2027-2032) & (USD/t) Table 16. North America Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 17. North America Radioisotopes in Medicine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 19. Europe Radioisotopes in Medicine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 21. Asia-Pacific Radioisotopes in Medicine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 23. Latin America Radioisotopes in Medicine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 25. Middle East and Africa Radioisotopes in Medicine Sales by Type (2021-2026) & (US$ Million) Table 26. Radioisotopes in Medicine Industry Trends Table 27. Radioisotopes in Medicine Industry Drivers Table 28. Radioisotopes in Medicine Industry Opportunities and Challenges Table 29. Radioisotopes in Medicine Industry Restraints Table 30. Global Radioisotopes in Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Radioisotopes in Medicine Revenue Market Share by Company (2021-2026) Table 32. Global Radioisotopes in Medicine Sales by Company (2021-2026) & (t) Table 33. Global Radioisotopes in Medicine Sales Share by Company (2021-2026) Table 34. Global Radioisotopes in Medicine Market Price by Company (2021-2026) & (USD/t) Table 35. Global Radioisotopes in Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Radioisotopes in Medicine Major Company Production Sites and Headquarters Table 37. Global Radioisotopes in Medicine Company, Product Type & Application Table 38. Global Radioisotopes in Medicine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Radioisotopes in Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Radioisotopes in Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Radioisotopes in Medicine Sales by Region (2021-2026) & (t) Table 43. Global Radioisotopes in Medicine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Radioisotopes in Medicine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Radioisotopes in Medicine Sales Market Share in Value by Region (2021-2026) Table 46. Global Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 47. Global Radioisotopes in Medicine Sales by Region (2027-2032) & (t) Table 48. Global Radioisotopes in Medicine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Radioisotopes in Medicine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Radioisotopes in Medicine Sales Market Share in Value by Region (2027-2032) Table 51. Global Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 52. Global Radioisotopes in Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 54. Global Radioisotopes in Medicine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Radioisotopes in Medicine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Radioisotopes in Medicine Sales Market Share in Value by Application (2021-2026) Table 57. Global Radioisotopes in Medicine Price by Application (2021-2026) & (USD/t) Table 58. Global Radioisotopes in Medicine Sales by Application (2027-2032) & (t) Table 59. Global Radioisotopes in Medicine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Radioisotopes in Medicine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Radioisotopes in Medicine Sales Market Share in Value by Application (2027-2032) Table 62. Global Radioisotopes in Medicine Price by Application (2027-2032) & (USD/t) Table 63. North America Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 64. North America Radioisotopes in Medicine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 66. Europe Radioisotopes in Medicine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 68. Asia-Pacific Radioisotopes in Medicine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 70. Latin America Radioisotopes in Medicine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 72. Middle East and Africa Radioisotopes in Medicine Sales by Application (2021-2026) & (US$ Million) Table 73. ANSTO Company Information Table 74. ANSTO Business Overview Table 75. ANSTO Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. ANSTO Radioisotopes in Medicine Product Portfolio Table 77. ANSTO Recent Development Table 78. China National Nuclear Corporation Company Information Table 79. China National Nuclear Corporation Business Overview Table 80. China National Nuclear Corporation Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. China National Nuclear Corporation Radioisotopes in Medicine Product Portfolio Table 82. China National Nuclear Corporation Recent Development Table 83. Eckert & Ziegler Strahlen Company Information Table 84. Eckert & Ziegler Strahlen Business Overview Table 85. Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolio Table 87. Eckert & Ziegler Strahlen Recent Development Table 88. IRE Company Information Table 89. IRE Business Overview Table 90. IRE Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. IRE Radioisotopes in Medicine Product Portfolio Table 92. IRE Recent Development Table 93. Nordion Company Information Table 94. Nordion Business Overview Table 95. Nordion Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Nordion Radioisotopes in Medicine Product Portfolio Table 97. Nordion Recent Development Table 98. NorthStar Medical Radioisotopes Company Information Table 99. NorthStar Medical Radioisotopes Business Overview Table 100. NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolio Table 102. NorthStar Medical Radioisotopes Recent Development Table 103. NRG Company Information Table 104. NRG Business Overview Table 105. NRG Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. NRG Radioisotopes in Medicine Product Portfolio Table 107. NRG Recent Development Table 108. NTP Radioisotopes Company Information Table 109. NTP Radioisotopes Business Overview Table 110. NTP Radioisotopes Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. NTP Radioisotopes Radioisotopes in Medicine Product Portfolio Table 112. NTP Radioisotopes Recent Development Table 113. Polatom Company Information Table 114. Polatom Business Overview Table 115. Polatom Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 116. Polatom Radioisotopes in Medicine Product Portfolio Table 117. Polatom Recent Development Table 118. Rosatom Company Information Table 119. Rosatom Business Overview Table 120. Rosatom Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 121. Rosatom Radioisotopes in Medicine Product Portfolio Table 122. Rosatom Recent Development Table 123. SHINE Technologies Company Information Table 124. SHINE Technologies Business Overview Table 125. SHINE Technologies Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 126. SHINE Technologies Radioisotopes in Medicine Product Portfolio Table 127. SHINE Technologies Recent Development Table 128. North America Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 129. North America Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 130. North America Radioisotopes in Medicine Sales Market Share by Country (2021-2026) Table 131. North America Radioisotopes in Medicine Sales Forecast by Country (2027-2032) & (t) Table 132. North America Radioisotopes in Medicine Sales Market Share Forecast by Country (2027-2032) Table 133. North America Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Radioisotopes in Medicine Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Radioisotopes in Medicine Market Share by Country (2021-2026) Table 136. North America Radioisotopes in Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Radioisotopes in Medicine Market Share Forecast by Country (2027-2032) Table 138. Europe Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 139. Europe Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 140. Europe Radioisotopes in Medicine Sales Market Share by Country (2021-2026) Table 141. Europe Radioisotopes in Medicine Sales Forecast by Country (2027-2032) & (t) Table 142. Europe Radioisotopes in Medicine Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Radioisotopes in Medicine Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Radioisotopes in Medicine Market Share by Country (2021-2026) Table 146. Europe Radioisotopes in Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Radioisotopes in Medicine Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 150. Asia-Pacific Radioisotopes in Medicine Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Radioisotopes in Medicine Sales Forecast by Country (2027-2032) & (t) Table 152. Asia-Pacific Radioisotopes in Medicine Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Radioisotopes in Medicine Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Radioisotopes in Medicine Market Share by Country (2021-2026) Table 156. Asia-Pacific Radioisotopes in Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Radioisotopes in Medicine Market Share Forecast by Country (2027-2032) Table 158. Latin America Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 159. Latin America Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 160. Latin America Radioisotopes in Medicine Sales Market Share by Country (2021-2026) Table 161. Latin America Radioisotopes in Medicine Sales Forecast by Country (2027-2032) & (t) Table 162. Latin America Radioisotopes in Medicine Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Radioisotopes in Medicine Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Radioisotopes in Medicine Market Share by Country (2021-2026) Table 166. Latin America Radioisotopes in Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Radioisotopes in Medicine Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 170. Middle East and Africa Radioisotopes in Medicine Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Radioisotopes in Medicine Sales Forecast by Country (2027-2032) & (t) Table 172. Middle East and Africa Radioisotopes in Medicine Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Radioisotopes in Medicine Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Radioisotopes in Medicine Market Share by Country (2021-2026) Table 176. Middle East and Africa Radioisotopes in Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Radioisotopes in Medicine Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Radioisotopes in Medicine Distributors List Table 181. Radioisotopes in Medicine Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Radioisotopes in Medicine Image Figure 2. Global Radioisotopes in Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radioisotopes in Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Radioisotopes in Medicine Sales (2021-2032) & (t) Figure 5. Tc-99m Image Figure 6. Global Tc-99m Sales YoY Growth (2021-2032) & (t) Figure 7. Iodine Radioisotopes Image Figure 8. Global Iodine Radioisotopes Sales YoY Growth (2021-2032) & (t) Figure 9. Cobalt-60 Image Figure 10. Global Cobalt-60 Sales YoY Growth (2021-2032) & (t) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (t) Figure 13. Global Radioisotopes in Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Radioisotopes in Medicine Market Share by Type 2025 VS 2032 Figure 15. North America Radioisotopes in Medicine Sales Market Share in Volume by Type in 2025 Figure 16. North America Radioisotopes in Medicine Sales Market Share in Value by Type in 2025 Figure 17. Europe Radioisotopes in Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Radioisotopes in Medicine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Radioisotopes in Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Radioisotopes in Medicine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Radioisotopes in Medicine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Radioisotopes in Medicine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Radioisotopes in Medicine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Radioisotopes in Medicine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Radioisotopes in Medicine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Nuclear Therapy Image Figure 28. Global Nuclear Therapy Sales YoY Growth (2021-2032) & (t) Figure 29. Equipment Radioactive Source Image Figure 30. Global Equipment Radioactive Source Sales YoY Growth (2021-2032) & (t) Figure 31. Diagnosis Image Figure 32. Global Diagnosis Sales YoY Growth (2021-2032) & (t) Figure 33. Global Radioisotopes in Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Radioisotopes in Medicine Market Share by Application 2025 VS 2032 Figure 35. North America Radioisotopes in Medicine Sales Market Share in Volume by Application in 2025 Figure 36. North America Radioisotopes in Medicine Sales Market Share in Value by Application in 2025 Figure 37. Europe Radioisotopes in Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Radioisotopes in Medicine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Radioisotopes in Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Radioisotopes in Medicine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Radioisotopes in Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Radioisotopes in Medicine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Radioisotopes in Medicine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Radioisotopes in Medicine Sales Market Share in Value by Application in 2025 Figure 45. North America Radioisotopes in Medicine Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. North America Radioisotopes in Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Radioisotopes in Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Radioisotopes in Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Radioisotopes in Medicine Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Europe Radioisotopes in Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Radioisotopes in Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Radioisotopes in Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Radioisotopes in Medicine Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Asia-Pacific Radioisotopes in Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Radioisotopes in Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Radioisotopes in Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Radioisotopes in Medicine Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Latin America Radioisotopes in Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Radioisotopes in Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Radioisotopes in Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Radioisotopes in Medicine Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Middle East and Africa Radioisotopes in Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Radioisotopes in Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Radioisotopes in Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Radioisotopes in Medicine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Radioisotopes in Medicine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • Iodine Radioisotopes
  • Cobalt-60
  • Others
Applications
  • Nuclear Therapy
  • Equipment Radioactive Source
  • Diagnosis
Companies covered
  • ANSTO
  • China National Nuclear Corporation
  • Eckert & Ziegler Strahlen
  • IRE
  • Nordion
  • NorthStar Medical Radioisotopes
  • NRG
  • NTP Radioisotopes
  • Polatom
  • Rosatom
  • SHINE Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radioisotopes in Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Radioisotopes in Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Radioisotopes in Medicine Market by Type
  6. 1.3.1 Tc-99m
  7. 1.3.2 Iodine Radioisotopes
  8. 1.3.3 Cobalt-60
  9. 1.3.4 Others
  10. 1.4 Global Radioisotopes in Medicine Market Size by Type
  11. 1.4.1 Global Radioisotopes in Medicine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Radioisotopes in Medicine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Radioisotopes in Medicine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Radioisotopes in Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Radioisotopes in Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Radioisotopes in Medicine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Radioisotopes in Medicine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Radioisotopes in Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Radioisotopes in Medicine Industry Trends
  2. 2.2 Radioisotopes in Medicine Industry Drivers
  3. 2.3 Radioisotopes in Medicine Industry Opportunities and Challenges
  4. 2.4 Radioisotopes in Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Radioisotopes in Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Radioisotopes in Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Radioisotopes in Medicine Price (2021-2026)
  4. 3.4 Global Radioisotopes in Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radioisotopes in Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Radioisotopes in Medicine Company, Product Type & Application
  7. 3.7 Global Radioisotopes in Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radioisotopes in Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radioisotopes in Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radioisotopes in Medicine Tier 1, Tier 2, and Tier 3
4 Radioisotopes in Medicine Regional Status and Outlook
  1. 4.1 Global Radioisotopes in Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Radioisotopes in Medicine Historic Market Size by Region
  3. 4.2.1 Global Radioisotopes in Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Radioisotopes in Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Radioisotopes in Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Radioisotopes in Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Radioisotopes in Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Radioisotopes in Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Radioisotopes in Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Radioisotopes in Medicine by Application
  1. 5.1 Radioisotopes in Medicine Market by Application
  2. 5.1.1 Nuclear Therapy
  3. 5.1.2 Equipment Radioactive Source
  4. 5.1.3 Diagnosis
  5. 5.2 Global Radioisotopes in Medicine Market Size by Application
  6. 5.2.1 Global Radioisotopes in Medicine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Radioisotopes in Medicine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Radioisotopes in Medicine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Radioisotopes in Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Radioisotopes in Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Radioisotopes in Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Radioisotopes in Medicine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Radioisotopes in Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ANSTO
  2. 6.1.1 ANSTO Company Information
  3. 6.1.2 ANSTO Business Overview
  4. 6.1.3 ANSTO Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ANSTO Radioisotopes in Medicine Product Portfolio
  6. 6.1.5 ANSTO Recent Developments
  7. 6.2 China National Nuclear Corporation
  8. 6.2.1 China National Nuclear Corporation Company Information
  9. 6.2.2 China National Nuclear Corporation Business Overview
  10. 6.2.3 China National Nuclear Corporation Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 China National Nuclear Corporation Radioisotopes in Medicine Product Portfolio
  12. 6.2.5 China National Nuclear Corporation Recent Developments
  13. 6.3 Eckert & Ziegler Strahlen
  14. 6.3.1 Eckert & Ziegler Strahlen Company Information
  15. 6.3.2 Eckert & Ziegler Strahlen Business Overview
  16. 6.3.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolio
  18. 6.3.5 Eckert & Ziegler Strahlen Recent Developments
  19. 6.4 IRE
  20. 6.4.1 IRE Company Information
  21. 6.4.2 IRE Business Overview
  22. 6.4.3 IRE Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 IRE Radioisotopes in Medicine Product Portfolio
  24. 6.4.5 IRE Recent Developments
  25. 6.5 Nordion
  26. 6.5.1 Nordion Company Information
  27. 6.5.2 Nordion Business Overview
  28. 6.5.3 Nordion Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nordion Radioisotopes in Medicine Product Portfolio
  30. 6.5.5 Nordion Recent Developments
  31. 6.6 NorthStar Medical Radioisotopes
  32. 6.6.1 NorthStar Medical Radioisotopes Company Information
  33. 6.6.2 NorthStar Medical Radioisotopes Business Overview
  34. 6.6.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolio
  36. 6.6.5 NorthStar Medical Radioisotopes Recent Developments
  37. 6.7 NRG
  38. 6.7.1 NRG Company Information
  39. 6.7.2 NRG Business Overview
  40. 6.7.3 NRG Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 NRG Radioisotopes in Medicine Product Portfolio
  42. 6.7.5 NRG Recent Developments
  43. 6.8 NTP Radioisotopes
  44. 6.8.1 NTP Radioisotopes Company Information
  45. 6.8.2 NTP Radioisotopes Business Overview
  46. 6.8.3 NTP Radioisotopes Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 NTP Radioisotopes Radioisotopes in Medicine Product Portfolio
  48. 6.8.5 NTP Radioisotopes Recent Developments
  49. 6.9 Polatom
  50. 6.9.1 Polatom Company Information
  51. 6.9.2 Polatom Business Overview
  52. 6.9.3 Polatom Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Polatom Radioisotopes in Medicine Product Portfolio
  54. 6.9.5 Polatom Recent Developments
  55. 6.10 Rosatom
  56. 6.10.1 Rosatom Company Information
  57. 6.10.2 Rosatom Business Overview
  58. 6.10.3 Rosatom Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Rosatom Radioisotopes in Medicine Product Portfolio
  60. 6.10.5 Rosatom Recent Developments
  61. 6.11 SHINE Technologies
  62. 6.11.1 SHINE Technologies Company Information
  63. 6.11.2 SHINE Technologies Business Overview
  64. 6.11.3 SHINE Technologies Radioisotopes in Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 SHINE Technologies Radioisotopes in Medicine Product Portfolio
  66. 6.11.5 SHINE Technologies Recent Developments
7 North America by Country
  1. 7.1 North America Radioisotopes in Medicine Sales by Country
  2. 7.1.1 North America Radioisotopes in Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Radioisotopes in Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Radioisotopes in Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Radioisotopes in Medicine Market Size by Country
  6. 7.2.1 North America Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Radioisotopes in Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Radioisotopes in Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Radioisotopes in Medicine Sales by Country
  2. 8.1.1 Europe Radioisotopes in Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Radioisotopes in Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Radioisotopes in Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Radioisotopes in Medicine Market Size by Country
  6. 8.2.1 Europe Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Radioisotopes in Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Radioisotopes in Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Radioisotopes in Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Radioisotopes in Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Radioisotopes in Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Radioisotopes in Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Radioisotopes in Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Radioisotopes in Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Radioisotopes in Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Radioisotopes in Medicine Sales by Country
  2. 10.1.1 South America Radioisotopes in Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Radioisotopes in Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Radioisotopes in Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Radioisotopes in Medicine Market Size by Country
  6. 10.2.1 South America Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Radioisotopes in Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Radioisotopes in Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Radioisotopes in Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Radioisotopes in Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Radioisotopes in Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Radioisotopes in Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Radioisotopes in Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Radioisotopes in Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Radioisotopes in Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Radioisotopes in Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Radioisotopes in Medicine Value Chain Analysis
  2. 12.1.1 Radioisotopes in Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Radioisotopes in Medicine Production Mode & Process
  7. 12.2 Radioisotopes in Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Radioisotopes in Medicine Distributors
  10. 12.2.3 Radioisotopes in Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst